Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed Growth (3y) (2014 - 2026)
Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 4,853.00 |
| 10 | Tonix Pharmaceuticals Holding | 141.53 Mn | 141.53 Mn | 5.30 Mn | -40.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.00 |
| Dec 31, 2025 | -183.00 |
| Sep 30, 2025 | -600.00 |
| Jun 30, 2025 | -638.00 |
| Mar 31, 2025 | -3,411.00 |
| Dec 31, 2024 | -7,878.00 |
| Sep 30, 2024 | -16,776.00 |
| Jun 30, 2024 | -14,968.00 |
| Mar 31, 2024 | -3,762.00 |
| Dec 31, 2023 | -2,338.00 |
| Sep 30, 2023 | -2,188.00 |
| Jun 30, 2023 | 898.00 |
| Mar 31, 2023 | 7,504.00 |
| Dec 31, 2022 | 29,627.00 |
| Sep 30, 2022 | 20,186.00 |
| Jun 30, 2022 | 12,239.00 |
| Mar 31, 2022 | 7,596.00 |
| Dec 31, 2021 | 9,725.00 |
| Sep 30, 2021 | 12,092.00 |
| Dec 31, 2020 | 2,029.00 |